000 01355 a2200409 4500
005 20250517192914.0
264 0 _c20180830
008 201808s 0 0 eng d
022 _a1432-1971
024 7 _a10.1007/s00246-017-1796-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiranda, Carlos
245 0 0 _aThe Use of Fecal Calprotectin Levels in the Fontan population.
_h[electronic resource]
260 _bPediatric cardiology
_cMar 2018
300 _a591-594 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCohort Studies
650 0 4 _aCross-Sectional Studies
650 0 4 _aFeces
_xchemistry
650 0 4 _aFemale
650 0 4 _aFontan Procedure
_xadverse effects
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdiagnosis
650 0 4 _aLeukocyte L1 Antigen Complex
_xanalysis
650 0 4 _aMale
650 0 4 _aProtein-Losing Enteropathies
_xdiagnosis
650 0 4 _aalpha 1-Antitrypsin
_xanalysis
700 1 _aTaqatqa, Anas
700 1 _aChapa-Rodriguez, Adrian
700 1 _aHolton, Jacob P
700 1 _aAwad, Sawsan M
773 0 _tPediatric cardiology
_gvol. 39
_gno. 3
_gp. 591-594
856 4 0 _uhttps://doi.org/10.1007/s00246-017-1796-1
_zAvailable from publisher's website
999 _c27929721
_d27929721